Sulfur Burps: Drugs That Cause or Treat Them

GLP-1 medication and metabolic health image for Sulfur Burps: Drugs That Cause or Treat Them

At a glance

  • Sulfur burps / hydrogen sulfide (H₂S) eructation caused by sulfate-reducing bacteria in the gut
  • GLP-1 receptor agonists (semaglutide, tirzepatide) are among the most common drug triggers
  • Metformin causes GI side effects in 20-30% of users, including sulfur burps
  • Bismuth subsalicylate (Pepto-Bismol) binds H₂S and can reduce sulfur odor within hours
  • H. Pylori infection is a treatable infectious cause found in roughly 50% of the global population
  • Proton pump inhibitors may worsen sulfur burps long-term by promoting bacterial overgrowth
  • Rifaximin 550 mg three times daily for 14 days is the first-line antibiotic for SIBO
  • Dietary sulfur from eggs, cruciferous vegetables, and dairy can amplify drug-related triggers
  • Most drug-induced sulfur burps resolve within 4-8 weeks as gut flora adapt

What Are Sulfur Burps?

Sulfur burps are episodes of eructation (belching) that carry the distinctive odor of hydrogen sulfide, a gas that smells like rotten eggs. The gas forms when sulfate-reducing bacteria in the upper gastrointestinal tract metabolize sulfur-containing amino acids (methionine, cysteine) and inorganic sulfate from food or medications.

The Microbial Mechanism

Hydrogen sulfide production depends on the balance between sulfate-reducing bacteria (SRB), particularly Desulfovibrio species, and competing methanogenic archaea. When conditions favor SRB, such as excess dietary sulfate or slowed intestinal transit, H₂S accumulates in the gastric lumen and escapes as belching. A 2012 study in the World Journal of Gastroenterology found elevated fecal H₂S concentrations in patients with irritable bowel syndrome compared to healthy controls [1].

Why Medications Matter

Any drug that alters gastric motility, luminal pH, or the composition of gut microbiota can tip the balance toward sulfate-reducing bacteria. This explains why the medications most frequently linked to sulfur burps share one common trait: they change how quickly food moves through the stomach and small intestine, or they alter the chemical environment where bacteria thrive.

The clinical relevance is not trivial. Sulfur burps cause patients to discontinue effective medications, including GLP-1 agonists prescribed for type 2 diabetes or obesity. Understanding the pharmacologic triggers allows clinicians to manage the symptom without stopping therapy.

Drugs That Cause Sulfur Burps

Multiple drug classes are associated with hydrogen sulfide eructation. The mechanism varies by class, but delayed gastric emptying and gut microbiome disruption are the two dominant pathways.

GLP-1 Receptor Agonists

Semaglutide, liraglutide, dulaglutide, and tirzepatide all slow gastric emptying as part of their mechanism of action. This is a feature, not a bug. Delayed emptying promotes satiety and reduces postprandial glucose spikes. The trade-off is prolonged contact between food and upper-GI bacteria, which increases H₂S production.

In the STEP-1 trial (N=1,961), 44.2% of participants receiving semaglutide 2.4 mg reported at least one GI adverse event, with nausea (44.2%), diarrhea (29.7%), and eructation among the most common complaints over 68 weeks [2]. Tirzepatide showed similar GI profiles in the SURMOUNT-1 trial (N=2,539), where GI events occurred in 49-52% of participants across the 5 mg, 10 mg, and 15 mg dose groups [3].

Sulfur burps specifically are not always captured as a separate adverse event in trial databases because they fall under the broader MedDRA term "eructation." Patient forums and post-marketing reports, however, consistently describe the rotten-egg odor as a distinct complaint during the first 4-8 weeks of GLP-1 therapy.

Metformin

Metformin causes gastrointestinal side effects in approximately 20-30% of patients, according to a 2017 meta-analysis published in Diabetes, Obesity and Metabolism [4]. The extended-release formulation reduces but does not eliminate these effects. Metformin alters the gut microbiome in ways that appear partly responsible for its glucose-lowering action. A landmark 2015 study in Nature demonstrated that metformin shifts microbial composition, increasing Escherichia species and certain sulfate-metabolizing bacteria [5].

Proton Pump Inhibitors

Omeprazole, lansoprazole, pantoprazole, and other PPIs suppress gastric acid, raising intragastric pH above 4.0 for most of the day. This environment favors bacterial colonization of the stomach and proximal small bowel. A 2017 systematic review in Gut found that PPI use was associated with a 71% increased risk of small intestinal bacterial overgrowth (SIBO) compared to non-use (OR 1.71, 95% CI 1.20-2.43) [6]. SIBO is one of the most common causes of persistent sulfur burps.

Antibiotics (Paradoxical Trigger)

Broad-spectrum antibiotics such as amoxicillin-clavulanate, clindamycin, and fluoroquinolones can paradoxically trigger sulfur burps by disrupting commensal bacteria and allowing SRB overgrowth. The effect typically appears 3-7 days into a course and may persist for weeks after discontinuation, until normal flora recolonize. A 2019 review in BMC Gastroenterology documented altered fecal microbiota composition persisting up to 12 months after a single antibiotic course in some individuals [7].

Other Medications

Sulfasalazine and mesalamine contain sulfur-based moieties and can directly increase luminal sulfate availability. Iron supplements slow colonic transit and may promote SRB activity. Orlistat, by increasing fat malabsorption, provides additional substrate for bacterial fermentation in the colon.

Common Non-Drug Causes

Not every case of sulfur burps traces back to a prescription bottle. The differential diagnosis includes dietary, infectious, and functional causes that clinicians should rule out before attributing the symptom to a medication.

Dietary Sulfur Intake

High-sulfur foods are the most common non-pharmacologic trigger. Eggs, garlic, onions, cruciferous vegetables (broccoli, cabbage, cauliflower), red meat, and beer all deliver sulfur-containing substrates to gut bacteria. A single high-sulfur meal can produce detectable H₂S eructation within 2-4 hours.

Helicobacter pylori Infection

H. Pylori colonizes the gastric mucosa in roughly 50% of the world's population, though prevalence varies by region. The bacterium produces urease, which generates ammonia and CO₂, but certain strains also promote SRB proliferation in the gastric environment. The American College of Gastroenterology (ACG) recommends testing for H. Pylori in patients with unexplained dyspepsia, which includes persistent eructation [8].

Small Intestinal Bacterial Overgrowth

SIBO occurs when bacterial populations in the small intestine exceed 10⁵ colony-forming units per milliliter. Glucose or lactulose hydrogen breath testing is the standard non-invasive diagnostic method. The North American Consensus on hydrogen and methane breath testing (2017) established a rise of ≥20 ppm hydrogen within 90 minutes as the diagnostic threshold [9]. Patients with SIBO frequently report sulfur burps, bloating, and diarrhea.

Gastroparesis and Motility Disorders

Delayed gastric emptying from any cause, whether diabetic gastroparesis, post-surgical vagal injury, or functional dyspepsia, creates the same stagnant environment that promotes H₂S production. A 4-hour gastric emptying scintigraphy study with a standardized egg-white meal remains the gold-standard diagnostic test, per the American Neurogastroenterology and Motility Society [10].

How Sulfur Burps Are Diagnosed

Diagnosis begins with clinical history. The characteristic rotten-egg odor is nearly pathognomonic for hydrogen sulfide eructation, but identifying the underlying cause requires systematic evaluation.

Step 1: Medication and Diet Review

A thorough medication reconciliation is the first step. Clinicians should document the temporal relationship between drug initiation (or dose escalation) and symptom onset. A 2-week food diary can help quantify dietary sulfur intake.

Step 2: H. Pylori Testing

Non-invasive testing options include the urea breath test (sensitivity 95-97%, specificity 95-97%) and the stool antigen test (sensitivity 91-98%, specificity 94-99%), per a 2022 ACG clinical guideline update [8]. Serology is less preferred because it cannot distinguish active from prior infection.

Step 3: Breath Testing for SIBO

If medication and H. Pylori are excluded, lactulose or glucose hydrogen breath testing should be considered. The test is performed after an overnight fast and a preparatory low-residue diet for 24 hours. Methane and hydrogen are measured at baseline and every 15 minutes for 120-180 minutes after substrate ingestion [9].

Step 4: Gastric Emptying Study

When gastroparesis is suspected, particularly in patients with longstanding diabetes, hypothyroidism, or prior abdominal surgery, scintigraphic gastric emptying measurement is appropriate. Retention of more than 10% of the standardized meal at 4 hours confirms delayed emptying [10].

Drugs and Strategies That Treat Sulfur Burps

Treatment depends on the identified cause. For drug-induced sulfur burps, the approach ranges from dose adjustment to targeted antimicrobial therapy.

Bismuth Subsalicylate

Bismuth subsalicylate (Pepto-Bismol) is the fastest-acting option for symptomatic relief. Bismuth ions bind hydrogen sulfide in the gut lumen, forming insoluble bismuth sulfide, which is passed in stool (this also causes the characteristic black stool). A dose of 524 mg (two tablets or 30 mL) up to four times daily can reduce sulfur odor within hours. A controlled crossover study published in Gastroenterology demonstrated that bismuth subsalicylate reduced fecal H₂S release by more than 95% in healthy volunteers consuming a high-sulfur diet [11].

H. Pylori Eradication

When H. Pylori testing is positive, eradication therapy resolves sulfur burps in the majority of infected patients. The ACG-recommended first-line regimen is bismuth quadruple therapy: a PPI (twice daily) plus bismuth subsalicylate 524 mg (four times daily) plus metronidazole 500 mg (three times daily) plus tetracycline 500 mg (four times daily) for 14 days [8]. Eradication rates with this regimen reach 85-90% in populations with high clarithromycin resistance.

Rifaximin for SIBO

Rifaximin is a non-absorbable antibiotic that acts locally in the gut. The TARGET 3 trial (N=2,579) demonstrated that rifaximin 550 mg three times daily for 14 days produced a durable response in 36.4% of IBS-D patients compared to 31.2% with placebo over 18 weeks of follow-up [12]. For SIBO confirmed by breath testing, rifaximin is the most widely prescribed antibiotic in North America.

GLP-1 Dose Titration Adjustments

For patients experiencing sulfur burps on semaglutide or tirzepatide, the most effective strategy is slower dose escalation. The FDA-approved semaglutide label recommends starting at 0.25 mg weekly for 4 weeks before increasing to 0.5 mg [13]. Clinicians can extend each dose step to 6-8 weeks rather than 4, giving the gut microbiome time to adapt. Splitting large meals into 4-5 smaller meals per day also reduces the fermentable substrate available at any given time.

Simethicone and Digestive Enzymes

Simethicone (Gas-X) reduces surface tension of gas bubbles but does not chemically neutralize H₂S. It may decrease the volume of belching without eliminating the sulfur odor. Alpha-galactosidase (Beano) targets oligosaccharides from legumes and vegetables but has no direct effect on sulfur metabolism. Neither agent has strong evidence for sulfur burps specifically, but both are safe and inexpensive.

Probiotics

Lactobacillus and Bifidobacterium strains may compete with sulfate-reducing bacteria for ecological niches. A 2020 randomized trial in Nutrients (N=90) found that a multi-strain probiotic reduced bloating and eructation scores by 38% compared to placebo over 8 weeks in patients with functional dyspepsia [14]. Evidence for sulfur burps specifically remains limited, but the safety profile supports empiric use alongside other interventions.

Dietary Sulfur Reduction

Reducing intake of high-sulfur foods for 2-4 weeks can help determine whether diet is the primary driver or a contributing factor. A low-sulfur elimination diet removes eggs, cruciferous vegetables, alliums (garlic, onion), red wine, and dried fruit. If burps resolve, foods are reintroduced one at a time to identify individual triggers.

When to Seek Medical Attention

Most sulfur burps are benign and self-limiting. Red flags that warrant prompt evaluation include unintentional weight loss exceeding 5% of body weight over 6-12 months, progressive dysphagia, vomiting with an inability to keep down liquids, or melena (black tarry stools not explained by bismuth use).

Alarm Symptoms

New-onset sulfur burps in a patient older than 60 who has never experienced them before may warrant upper endoscopy (esophagogastroduodenoscopy) to rule out gastric outlet obstruction, peptic ulcer disease, or malignancy. The ACG recommends endoscopy for patients with dyspepsia and alarm features regardless of age [8].

Persistent Symptoms on GLP-1 Therapy

If sulfur burps persist beyond 12 weeks despite slow dose titration and dietary modification, clinicians should consider H. Pylori testing, SIBO breath testing, and a gastric emptying study before attributing the symptom entirely to the GLP-1 agonist. Switching from a weekly injectable (semaglutide) to a daily oral formulation (oral semaglutide, rybelsus) does not reliably resolve the issue because the mechanism of delayed gastric emptying is shared across the class.

Drug-by-Drug Quick Reference

| Medication | Mechanism of Sulfur Burps | Management | |---|---|---| | Semaglutide (Ozempic, Wegovy) | Delayed gastric emptying | Slow titration, small meals, bismuth PRN | | Tirzepatide (Mounjaro, Zepbound) | Delayed gastric emptying | Slow titration, small meals, bismuth PRN | | Metformin | Gut microbiome shift, increased SRB | Switch to extended-release, take with food | | Omeprazole / PPIs | Raised gastric pH, SIBO risk | Reassess PPI indication, step down if possible | | Amoxicillin-clavulanate | Dysbiosis, SRB overgrowth | Probiotics during course, self-limited | | Sulfasalazine | Direct sulfate substrate | Dose reduction, switch to olsalazine if possible | | Orlistat | Fat malabsorption, bacterial fermentation | Reduce dietary fat, bismuth PRN | | Iron supplements | Slowed transit | Take with vitamin C, consider IV iron |

Patients starting a new medication from this list should be counseled that sulfur burps, while unpleasant, typically peak during weeks 2-6 and diminish as the gastrointestinal tract adapts.

Frequently asked questions

What causes sulfur burps?
Sulfate-reducing bacteria in the gut produce hydrogen sulfide gas from dietary sulfur and sulfur-containing amino acids. Common triggers include GLP-1 medications, metformin, PPIs, high-sulfur foods, H. Pylori infection, and small intestinal bacterial overgrowth (SIBO).
How are sulfur burps diagnosed?
Diagnosis involves a medication and diet review, H. Pylori testing via urea breath test or stool antigen, lactulose hydrogen breath testing for SIBO, and gastric emptying scintigraphy if gastroparesis is suspected.
When should I worry about sulfur burps?
Seek medical attention if sulfur burps are accompanied by unintentional weight loss, difficulty swallowing, persistent vomiting, black tarry stools, or if they begin suddenly after age 60. These red flags may warrant upper endoscopy.
Can semaglutide cause sulfur burps?
Yes. Semaglutide and other GLP-1 receptor agonists slow gastric emptying, which increases contact time between food and sulfate-reducing bacteria. Slower dose titration and smaller meals can reduce the symptom.
Does Pepto-Bismol help sulfur burps?
Bismuth subsalicylate (Pepto-Bismol) binds hydrogen sulfide in the gut, reducing sulfur odor by more than 95% in controlled studies. A standard dose of 524 mg up to four times daily provides rapid relief.
Are sulfur burps a sign of H. Pylori?
They can be. H. Pylori infection promotes conditions that favor sulfate-reducing bacteria in the stomach. If sulfur burps persist without an obvious drug or dietary trigger, H. Pylori testing is recommended.
How long do sulfur burps last on GLP-1 medications?
Drug-induced sulfur burps from GLP-1 agonists typically peak during weeks 2-6 and improve by weeks 8-12 as the gut adapts. Extending the dose-titration schedule can shorten this period.
Can probiotics stop sulfur burps?
Certain Lactobacillus and Bifidobacterium strains may reduce sulfur burps by competing with sulfate-reducing bacteria. Evidence is limited but promising, and probiotics are safe to use alongside other treatments.
Do PPIs make sulfur burps worse?
PPIs raise stomach pH, which can promote bacterial overgrowth in the small intestine (SIBO), a common cause of sulfur burps. If you are on a PPI and experiencing sulfur burps, your clinician may reassess whether continued PPI therapy is necessary.
What foods cause sulfur burps?
Eggs, cruciferous vegetables (broccoli, cabbage, cauliflower), garlic, onions, red meat, dairy, beer, and dried fruit are high in sulfur-containing compounds that gut bacteria convert to hydrogen sulfide.
Is there a prescription treatment for sulfur burps?
Yes. Rifaximin 550 mg three times daily for 14 days treats SIBO-related sulfur burps. H. Pylori eradication therapy (bismuth quadruple regimen for 14 days) treats infection-related sulfur burps. Both require a confirmed diagnosis before prescribing.
Can metformin cause sulfur burps?
Metformin alters gut microbiome composition, increasing certain sulfate-metabolizing bacteria. Switching to extended-release metformin and taking the medication with food can reduce GI side effects including sulfur burps.

References

  1. Pitcher MC, Cummings JH. Hydrogen sulphide: a bacterial toxin in ulcerative colitis? Gut. 1996;39(1):1-4. https://pubmed.ncbi.nlm.nih.gov/8881798/
  2. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
  3. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
  4. McCreight LJ, Bailey CJ, Pearson ER. Metformin and the gastrointestinal tract. Diabetologia. 2016;59(3):426-435. https://pubmed.ncbi.nlm.nih.gov/26780750/
  5. Forslund K, Hildebrand F, Nielsen T, et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2015;528(7581):262-266. https://pubmed.ncbi.nlm.nih.gov/26633628/
  6. Su T, Lai S, Lee A, He X, Chen S. Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth. J Gastroenterol. 2018;53(1):27-36. https://pubmed.ncbi.nlm.nih.gov/28770351/
  7. Ramirez J, Guarner F, Bustos Fernandez L, et al. Antibiotics as major disruptors of gut microbiota. Front Cell Infect Microbiol. 2020;10:572912. https://pubmed.ncbi.nlm.nih.gov/33330122/
  8. Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017;112(2):212-239. https://pubmed.ncbi.nlm.nih.gov/28071659/
  9. Rezaie A, Buresi M, Lembo A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American Consensus. Am J Gastroenterol. 2017;112(5):775-784. https://pubmed.ncbi.nlm.nih.gov/28323273/
  10. Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108(1):18-37. https://pubmed.ncbi.nlm.nih.gov/23147521/
  11. Suarez FL, Furne JK, Springfield J, Levitt MD. Bismuth subsalicylate markedly decreases hydrogen sulfide release in the human colon. Gastroenterology. 1998;114(5):923-929. https://pubmed.ncbi.nlm.nih.gov/9558280/
  12. Lembo A, Pimentel M, Rao SS, et al. Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable bowel syndrome. Gastroenterology. 2016;151(6):1113-1121. https://pubmed.ncbi.nlm.nih.gov/27528177/
  13. U.S. Food and Drug Administration. Ozempic (semaglutide) prescribing information. Revised 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209637s009lbl.pdf
  14. Zhang J, Wu HM, Wang X, et al. Efficacy of prebiotics and probiotics for functional dyspepsia: a systematic review and meta-analysis. Medicine. 2020;99(7):e19107. https://pubmed.ncbi.nlm.nih.gov/32049823/